Schafer Discusses Oncology Value Frameworks With Managed Healthcare Executive
In the latest edition of Managed Healthcare Executive, Jeremy Schafer, Precision for Value senior vice president, director of payer access solutions, discusses value in oncology and explains how payers are using value frameworks in their drug management process. (more…)
Precision’s Messerschmidt Talks Immunotherapy with ASCO Post
Precision Oncology Chief Medical Officer Gerald Messerschmidt sits down to talk with ASCO Post‘s Ronald Piana regarding the future of immunotherapy. (more…)
Jena Discusses New PHE Preeclampsia Study With Orlando Sentinel
PHE Scientific Advisor Anupam Jena, coauthor of a new study on preeclampsia in the September issue of American Journal of Obstetrics & Gynecology, discussed the study’s findings and the growing economic impact of the condition with the Orlando Sentinel’s Amelia Cheatham. (more…)
Wilder on New Heart Drugs in MM&M: Drug Makers Need to Proactively Share Information With Payers
In a new article appearing in the latest MM&M, Precision for Value EVP and Managing Partner Kelly Wilder shares her perspective on the challenges of marketing new heart drugs. (more…)
Chad Clark Talks EU Expansion With Clinical OMICs
Precision for Medicine President Chad Clark speaks with Alex Philippides of Clinical OMICs to discuss Precision’s European expansion. (more…)